These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 4029182)

  • 1. Electrophysiologic effects, antiarrhythmic activity and pharmacokinetics of cibenzoline studied with programmed stimulation of the heart in patients with supraventricular reentrant tachycardias.
    Waleffe A; Dufour A; Aymard MF; Kulbertus H
    Eur Heart J; 1985 Mar; 6(3):253-60. PubMed ID: 4029182
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Electrophysiologic properties of cibenzoline in Wolff-Parkinson-White syndrome and atrioventricular nodal reentry tachycardia].
    Kühlkamp V; Ickrath O; Schmid F; Mayer F; Haasis R; Seipel L
    Z Kardiol; 1989 Oct; 78(10):640-6. PubMed ID: 2686251
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Cibenzoline: electrophysiologic effects of a new class I anti-arrhythmia agents in supraventricular tachycardia].
    Pfitzner P; Manz M; Schütz R; Lüderitz B
    Z Kardiol; 1989 Oct; 78(10):654-60. PubMed ID: 2686252
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Effect of a new class I anti-arrhythmia agent cibenzoline in patients with therapy refractory, sustained ventricular tachycardias].
    Kühlkamp V; Ickrath O; Haasis R; Seipel L
    Z Kardiol; 1988 Sep; 77(9):595-9. PubMed ID: 3195178
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Injectable and oral cibenzoline in the treatment of supraventricular tachycardia related to intranodal reentry or accessory atrioventricular conduction pathway].
    Fauchier JP; Rouesnel P; Breuillac JC; Cosnay P; Scheck F; Garnier LF
    Ann Cardiol Angeiol (Paris); 1994 Apr; 43(4):194-203. PubMed ID: 8024234
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Electrophysiologic effects and efficacy of cibenzoline in patients with supraventricular tachycardia.
    Fujiki A; Mizumaki K; Tani M; Yoshida S; Sasayama S
    J Cardiovasc Pharmacol; 1992 Sep; 20(3):375-9. PubMed ID: 1279281
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mechanisms of termination of supraventricular tachycardias by intravenous class III antiarrhythmic agents. A comparison of amiodarone and sotalol.
    Waleffe A; Nzayinambaho K; Rodriguez LM; Dehareng A; Kulbertus HE
    Eur Heart J; 1989 Dec; 10(12):1084-9. PubMed ID: 2606117
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Anti-arrhythmia and pro-arrhythmia effects of oral cibenzoline therapy in sustained ventricular tachycardia].
    Hoffmann E; Bach P; Haberl R; Mattke S; Steinbeck G
    Z Kardiol; 1992 Jul; 81(7):378-84. PubMed ID: 1509795
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antiarrhythmic use of cibenzoline, a new class 1 antiarrhythmic agent with class 3 and 4 properties, in patients with recurrent ventricular tachycardia.
    Cocco G; Strozzi C; Pansini R; Rochat N; Bulgarelli R; Padula A; Sfrisi C; Kamal Al Yassini A
    Eur Heart J; 1984 Feb; 5(2):108-14. PubMed ID: 6723683
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antiarrhythmic effects of cibenzoline.
    Miura DS; Keren G; Torres V; Butler B; Aogaichi K; Somberg JC
    Am Heart J; 1985 Apr; 109(4):827-33. PubMed ID: 3984837
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical efficacy and electrophysiologic effects of cibenzoline therapy in patients with ventricular arrhythmias.
    Browne KF; Prystowsky EN; Zipes DP; Chilson DA; Heger JJ
    J Am Coll Cardiol; 1984 Mar; 3(3):857-64. PubMed ID: 6693656
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Electrophysiologic mechanisms of adverse effects of class I antiarrhythmic drugs (cibenzoline, pilsicainide, disopyramide, procainamide) in induction of atrioventricular re-entrant tachycardia.
    Fujiki A; Tani M; Yoshida S; Inoue H
    Cardiovasc Drugs Ther; 1996 May; 10(2):159-66. PubMed ID: 8842508
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Electrophysiologic effects and efficacy of cibenzoline on stimulation-induced atrial fibrillation and flutter and implications for treatment of paroxysmal atrial fibrillation.
    Kühlkamp V; Meerhof J; Schmidt F; Mayer F; Ickrath O; Haasis R; Seipel L
    Am J Cardiol; 1990 Mar; 65(9):628-32. PubMed ID: 2309633
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Randomized crossover comparison of the electrophysiologic and antiarrhythmic efficacy of oral cibenzoline and sotalol for sustained ventricular tachycardia.
    Hoffmann E; Mattke S; Haberl R; Steinbeck G
    J Cardiovasc Pharmacol; 1993 Jan; 21(1):95-100. PubMed ID: 7678686
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Electrophysiologic effects and pharmacokinetics of intravenous penticainide (CM 7857).
    Aliot E; Munoz A; Khalife K; Necciari J; Gagnol JP; Gilgenkrantz JM
    Eur Heart J; 1987 Jun; 8(6):618-23. PubMed ID: 3622542
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Electrophysiological effects of a new antiarrhythmic agent, nicainoprol, in humans.
    Sen S; Rettig G; Ozbek C; Fröhlig G; Schieffer H; Bette L
    J Cardiovasc Pharmacol; 1986; 8(1):144-50. PubMed ID: 2419677
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical electrophysiology, efficacy and safety of chronic oral cibenzoline therapy in refractory ventricular tachycardia.
    Rothbart ST; Saksena S
    Am J Cardiol; 1986 Apr; 57(11):941-6. PubMed ID: 3515898
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Electrophysiologic effects of penticainide in patients with supraventricular tachycardia].
    Kühlkamp V; Mewis C; Mayer F; Seipel L
    Z Kardiol; 1990 Oct; 79(10):725-31. PubMed ID: 2087860
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Electrophysiologic and antiarrhythmic effects of carocainide in humans.
    Bach P; Steinbeck G
    J Cardiovasc Pharmacol; 1988 Dec; 12(6):637-42. PubMed ID: 2467080
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Electrophysiologic effect of sotalol in supraventricular tachycardias].
    Borggrefe M; Breithardt G
    Z Kardiol; 1985 Sep; 74(9):506-11. PubMed ID: 4060828
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.